ETBX-051
UNII BPG11IF0HW

Substance Identification & Data

This profile provides standardized clinical and technical data for Etbx-051, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BPG11IF0HW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2171537-82-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BPG11IF0HW
CAS Registry Number
2171537-82-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ETBX-051
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C143034
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
28285
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etbx-051. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ADENOVIRAL BRACHYURY VACCINE ETBX-051
AN ADENOVIRUS VECTOR CANCER VACCINE COMPOSED OF A REPLICATION-DEFECTIVE, SER OTYPE 5 ADENOVIRUS (AD5) THAT HAS BEEN MODIFIED BY REMOVAL OF THE E1, E2B AND E3 GENES AND INSERTION OF A MODIFIED HUMAN BRACHYURY PROTEIN-EXPRESSING GENE
ETBX-051

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus